119 related articles for article (PubMed ID: 7707164)
1. Trough:peak ratio of the blood pressure response to angiotensin converting enzyme inhibitors.
Salvetti A; Di Venanzio L; Arrighi P; Arzilli F
J Hypertens Suppl; 1994 Nov; 12(8):S91-4; discussion S94-5. PubMed ID: 7707164
[TBL] [Abstract][Full Text] [Related]
2. Trough/peak ratios of once daily angiotensin converting enzyme inhibitors and calcium antagonists.
Zannad F; Matzinger A; Larché J
Am J Hypertens; 1996 Jul; 9(7):633-43. PubMed ID: 8806975
[TBL] [Abstract][Full Text] [Related]
3. Combined inhibition of neutral endopeptidase and angiotensin-converting enzyme by sampatrilat in essential hypertension.
Wallis EJ; Ramsay LE; Hettiarachchi J
Clin Pharmacol Ther; 1998 Oct; 64(4):439-49. PubMed ID: 9797801
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic, pharmacokinetic, and therapeutic differences among ACE inhibitors.
White CM
Pharmacotherapy; 1998; 18(3):588-99. PubMed ID: 9620109
[TBL] [Abstract][Full Text] [Related]
5. Spectral analysis of 24 h blood pressure monitoring in the assessment of trough: peak ratio. A randomized, placebo-controlled, cross-over comparison of ramipril and enalapril.
Modesti PA; Toccafondi S; Carnemolla A; Rocchi F; Costoli A; Torri M; Tortoli P
Blood Press Monit; 1997 Dec; 2(6):283-287. PubMed ID: 10234131
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of angiotensin converting enzyme inhibitors on the vasodepressor and prostacyclin responses to bradykinin.
Brown NJ; Ryder D; Gainer JV; Morrow JD; Nadeau J
J Pharmacol Exp Ther; 1996 Nov; 279(2):703-12. PubMed ID: 8930174
[TBL] [Abstract][Full Text] [Related]
7. Effect of angiotensin-converting enzyme inhibitors on the power spectrum of heart rate variability in post-myocardial infarction patients.
Kontopoulos AG; Athyros VG; Papageorgiou AA; Skeberis VM; Basayiannis EC; Boudoulas H
Coron Artery Dis; 1997; 8(8-9):517-24. PubMed ID: 9431480
[TBL] [Abstract][Full Text] [Related]
8. Critical assessment of ACE inhibitors. Part 2.
Howes LG
Aust Fam Physician; 1995 Apr; 24(4):639, 641-3. PubMed ID: 7771972
[TBL] [Abstract][Full Text] [Related]
9. The dose-response relationship with angiotensin converting enzyme inhibitors: effects on blood pressure and biochemical parameters.
Lees KR
J Hypertens Suppl; 1992 Jul; 10(5):S3-11. PubMed ID: 1403231
[TBL] [Abstract][Full Text] [Related]
10. Lisinopril versus enalapril: evaluation of trough:peak ratio by ambulatory blood pressure monitoring.
Diamant M; Vincent HH
J Hum Hypertens; 1999 Jun; 13(6):405-12. PubMed ID: 10408591
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors: an update.
Song JC; White CM
Clin Pharmacokinet; 2002; 41(3):207-24. PubMed ID: 11929321
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy and safety of dual ACE/NEP inhibitor GW660511X in mild-to-moderate hypertensive patients.
Johnson AG; Pearce GL; Danoff TM
J Hum Hypertens; 2006 Jul; 20(7):496-503. PubMed ID: 16543907
[TBL] [Abstract][Full Text] [Related]
13. Use of trough:peak ratio in the assessment of antihypertensive drug therapy.
Myers MG
Can J Cardiol; 1994 Nov; 10 Suppl D():17D-20D. PubMed ID: 7954034
[TBL] [Abstract][Full Text] [Related]
14. Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned?
Erman A; Boner G; van Dijk DJ
J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):365-8. PubMed ID: 11967825
[TBL] [Abstract][Full Text] [Related]
15. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ
Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
[TBL] [Abstract][Full Text] [Related]
16. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy of perindopril and enalapril once daily using 24-hour ambulatory blood pressure monitoring.
Yusoff K; Razak TA; Yusof N; Rafee NM
Int J Clin Pract; 1999 Jun; 53(4):277-80. PubMed ID: 10563072
[TBL] [Abstract][Full Text] [Related]
18. Regression of ventricular and vascular hypertrophy: are there differences between structurally different angiotensin-converting enzyme inhibitors?
Raasch W; Bartels T; Schwartz C; Häuser W; Rütten H; Dominiak P
J Hypertens; 2002 Dec; 20(12):2495-504. PubMed ID: 12473875
[TBL] [Abstract][Full Text] [Related]
19. Reference-based pricing of prescription drugs: exploring the equivalence of angiotensin-converting-enzyme inhibitors.
Bourgault C; Elstein E; Le Lorier J; Suissa S
CMAJ; 1999 Aug; 161(3):255-60. PubMed ID: 10463046
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive efficacy of angiotensin converting enzyme inhibition and aspirin counteraction.
Guazzi MD; Campodonico J; Celeste F; Guazzi M; Santambrogio G; Rossi M; Trabattoni D; Alimento M
Clin Pharmacol Ther; 1998 Jan; 63(1):79-86. PubMed ID: 9465844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
